Born on the frontlines of medical action
The Drugs for Neglected Diseases initiative (DNDi) is an international, not-for-profit research and development organization that develops lifesaving medicines for people with neglected diseases around the world. We use the power of innovation, open science, partnerships, and advocacy to find solutions to a great injustice: the lack of medicines for life-threatening diseases that disproportionately impact poor and marginalized people.
DNDi was launched in 2003 when five leading research institutes from Brazil, India, Kenya, Malaysia, and France teamed up with Doctors Without Borders/Médecins Sans Frontières (MSF) to launch an alternative, not-for-profit model for developing drugs for neglected populations. Together, we are proud to have delivered thirteen new treatments for six diseases that have saved millions of lives – and we aim to deliver a total of 25 treatments by 2028.
DNDi founding partners
DNDi has built a team of more than 240 employees working across nine offices. DNDi North America, created in 2008 and based in New York City, is a registered 501(c)(3) non-profit that works to strengthen and expand scientific networks, policy and advocacy influence, partner development, communications, and in particular, fundraising efforts to enhance DNDi’s global impact.
Discover our projects in more detail on our international website at dndi.org.
COVID-19 Policy Report: Another triumph of science, but defeat for access?
DNDi North America Staff
Help neglected patients
To date, we have delivered thirteen new treatments, saving millions of lives.
Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there.
DNDi North America Board of Directors
Current job opportunities
We are looking for committed and talented individuals to join us in our efforts to develop safe, effective, and affordable treatments for diseases affecting some of the world’s poorest and most neglected communities.
Get our latest news, personal stories, research articles, and job opportunities.